Ambudkar, Suresh V.
National Cancer Institute (NCI),
United States
2025 Rank: 97358
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1533 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97358 | 76453 |
| Total Cites | 911 | 1057 |
| H-index | 11 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 8 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 69 | 76 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 368 | 418 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 729 | 758 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.39 |
| Self-Citation Percentage |
13.81%
|
|
Ambudkar, Suresh V.
National Institutes of Health (NIH),
United States
2024 Rank: 92188
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1635 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92188 | 48737 |
| Total Cites | 935 | 1124 |
| H-index | 12 | 13 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 8 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 87 | 105 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 363 | 469 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 693 | 727 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.55 |
| Self-Citation Percentage |
16.81%
|
|
Ambudkar, Suresh V.
National Cancer Institute (NCI),
United States
2023 Rank: 52081
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1067 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52081 | 38884 |
| Total Cites | 993 | 1189 |
| H-index | 13 | 15 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 8 | 13 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 89 | 100 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 387 | 461 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 769 | 809 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.47 |
| Self-Citation Percentage |
16.48%
|
|
Ambudkar, Suresh V.
National Cancer Institute (NCI),
United States
2022 Rank: 66314
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1560 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66314 | 41909 |
| Total Cites | 1121 | 1322 |
| H-index | 14 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 7 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 102 | 113 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 407 | 470 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 837 | 877 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.51 |
| Self-Citation Percentage |
15.20%
|
|
Ambudkar, Suresh V.
National Cancer Institute (NCI),
United States
2021 Rank: 40752
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 926 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40752 | 32693 |
| Total Cites | 1687 | 2007 |
| H-index | 19 | 19 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 13 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 158 | 174 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 630 | 726 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1262 | 1326 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.51 |
| Self-Citation Percentage |
15.94%
|
|
Ambudkar, Suresh V.
National Cancer Institute,
United States
2020 Rank: 41932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 813 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41932 | 26165 |
| Total Cites | 1257 | 1562 |
| H-index | 16 | 18 |
| Hm-index | 7 | 9 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 15 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 116 | 145 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 457 | 569 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 947 | 1015 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.54 |
| Self-Citation Percentage |
19.53%
|
|